Nasdaq
$127.71▼ 0.66%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $705.6MShares out 5.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
24- 10.13Pre-market26.10.13 21:008-KKey event#●●●#●●●#●●●
MESA LABORATORIES INC /CO/
Mesa Laboratories has finalized a restructuring program to improve profitability in its Clinical Genomics division, involving the elimination of approximately 40 positions and the exit of its Hamburg, Germany facility. The company expects to reduce annualized operating costs by approximately $9.3 million, with $4.3 million to be reinvested, resulting in a net annualized savings of $5.0 million. Total pre-tax charges are estimated between $2.6 million and $3.4 million, and updated fiscal year 2027 guidance will be provided during the second quarter earnings release on November 9, 2026.…more
$127.71-0.66%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9Regular26.10.10 04:46SCHEDULE 13GOwnership
MESA LABORATORIES INC /CO/
Wasatch Advisors LP has filed a Schedule 13G, reporting a beneficial ownership of more than 5% of Mesa Laboratories Inc. The filing was submitted on October 9, 2026.…more
$127.71-0.66%vs prev closeView filingShare - 9.11Regular26.09.12 03:134Ownership
MESA LABORATORIES INC /CO/
Mark Christopher Capone, a director of Mesa Laboratories, Inc., reported changes in his beneficial ownership of securities effective September 9, 2026. This filing is a standard Form 4 disclosure regarding insider stock holdings.…more
$127.71-0.66%vs prev closeView filingShare
23 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.13Pre-market26.10.13 21:00#●●●#●●●#●●●
Mesa Laboratories Announces Restructuring Plan to Cut Annual Costs by $9.3 Million…more
Mesa Laboratories announced a restructuring plan, including a 6% workforce reduction, aimed at cutting $9.3 million in annual operating costs. The company plans to reinvest a portion of these savings into high-growth areas to improve overall profitability.…more
$127.71-0.66%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.9After-hours26.10.10 05:00
●●●●●●●● ●●●●● ●●●●●●
Mesa Laboratories has announced a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15, 2026, to shareholders of record as of November 30, 2026.…more
$127.71-0.66%vs prev close - 8.10After-hours26.08.11 05:01
●●●●●●●● ●●●●● ●●●●●●
메사 래보라토리스는 1분기 매출이 전년 동기 대비 1% 증가하고 영업이익은 129% 급증하며 수익성이 크게 개선되었습니다. 부채 상환을 통한 재무 건전성 강화와 함께 핵심 사업부의 성장을 바탕으로 견조한 실적을 기록했습니다.…more
$127.71-0.66%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report